Ceralasertib Uses, Dosage, Side Effects and more
Ceralasertib is under investigation in clinical trial NCT03682289 (Phase II Trial of AZD6738 Alone and in Combination With Olaparib).
| Attribute | Details |
|---|---|
| Trade Name | Ceralasertib |
| Generic | Ceralasertib |
| Ceralasertib Other Names | Ceralasertib |
| Type | |
| Formula | C20H24N6O2S |
| Weight | Average: 412.51 Monoisotopic: 412.168145211 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
